215 related articles for article (PubMed ID: 31759087)
1. A novel class of cardioprotective small-molecule PTP inhibitors.
Antonucci S; Di Sante M; Sileikyte J; Deveraux J; Bauer T; Bround MJ; Menabò R; Paillard M; Alanova P; Carraro M; Ovize M; Molkentin JD; Cohen M; Forte MA; Bernardi P; Di Lisa F; Murphy E
Pharmacol Res; 2020 Jan; 151():104548. PubMed ID: 31759087
[TBL] [Abstract][Full Text] [Related]
2. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
[TBL] [Abstract][Full Text] [Related]
3. Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.
Amanakis G; Sun J; Fergusson MM; McGinty S; Liu C; Molkentin JD; Murphy E
Cardiovasc Res; 2021 Jan; 117(1):212-223. PubMed ID: 32129829
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury.
Ikeda G; Matoba T; Ishikita A; Nagaoka K; Nakano K; Koga JI; Tsutsui H; Egashira K
J Am Heart Assoc; 2021 Jun; 10(12):e019521. PubMed ID: 34056918
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
6. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms.
Chatzianastasiou A; Bibli SI; Andreadou I; Efentakis P; Kaludercic N; Wood ME; Whiteman M; Di Lisa F; Daiber A; Manolopoulos VG; Szabó C; Papapetropoulos A
J Pharmacol Exp Ther; 2016 Sep; 358(3):431-40. PubMed ID: 27342567
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of a Novel Necrosis Inhibitor, 7-Amino-Indole, in Myocardial Ischemia-Reperfusion Injury.
Hwang IC; Kim JY; Kim JH; Lee JE; Seo JY; Lee JW; Park J; Yang HM; Kim SH; Cho HJ; Kim HS
Hypertension; 2018 Jun; 71(6):1143-1155. PubMed ID: 29661840
[TBL] [Abstract][Full Text] [Related]
10. Synergistic protective effect of cyclosporin A and rotenone against hypoxia-reoxygenation in cardiomyocytes.
Teixeira G; Abrial M; Portier K; Chiari P; Couture-Lepetit E; Tourneur Y; Ovize M; Gharib A
J Mol Cell Cardiol; 2013 Mar; 56():55-62. PubMed ID: 23238221
[TBL] [Abstract][Full Text] [Related]
11. HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion injury.
Yang J; He J; Ismail M; Tweeten S; Zeng F; Gao L; Ballinger S; Young M; Prabhu SD; Rowe GC; Zhang J; Zhou L; Xie M
J Mol Cell Cardiol; 2019 May; 130():36-48. PubMed ID: 30880250
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the mPTP and Lipid Peroxidation Is Additively Protective Against I/R Injury.
Mendoza A; Patel P; Robichaux D; Ramirez D; Karch J
Circ Res; 2024 May; 134(10):1292-1305. PubMed ID: 38618716
[TBL] [Abstract][Full Text] [Related]
13. Cyclophilin D-mediated regulation of the permeability transition pore is altered in mice lacking the mitochondrial calcium uniporter.
Parks RJ; Menazza S; Holmström KM; Amanakis G; Fergusson M; Ma H; Aponte AM; Bernardi P; Finkel T; Murphy E
Cardiovasc Res; 2019 Feb; 115(2):385-394. PubMed ID: 30165576
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Cyclophilin D and Calcium in Isoflurane-induced Preconditioning.
Teixeira G; Chiari P; Fauconnier J; Abrial M; Couture-Lepetit E; Harisseh R; Pillot B; Lacampagne A; Tourneur Y; Gharib A; Ovize M
Anesthesiology; 2015 Dec; 123(6):1374-84. PubMed ID: 26460965
[TBL] [Abstract][Full Text] [Related]
15. The novel H
Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
[TBL] [Abstract][Full Text] [Related]
16. Tissue kallikrein is required for the cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse.
Youcef G; Belaidi E; Waeckel L; Fazal L; Clemessy M; Vincent MP; Zadigue G; Richer C; Alhenc-Gelas F; Ovize M; Pizard A
Biochem Pharmacol; 2015 Mar; 94(1):22-9. PubMed ID: 25623731
[TBL] [Abstract][Full Text] [Related]
17. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.
Di Lisa F; Menabò R; Canton M; Barile M; Bernardi P
J Biol Chem; 2001 Jan; 276(4):2571-5. PubMed ID: 11073947
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection.
Javadov S; Karmazyn M
Cell Physiol Biochem; 2007; 20(1-4):1-22. PubMed ID: 17595511
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion.
Ruiz-Meana M; Garcia-Dorado D; Miró-Casas E; Abellán A; Soler-Soler J
Cardiovasc Res; 2006 Sep; 71(4):715-24. PubMed ID: 16860295
[TBL] [Abstract][Full Text] [Related]
20. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
